Citation Impact
Citing Papers
Tumor Regression by Targeted Gene Delivery to the Neovasculature
2002 Science
A mechanosensory complex that mediates the endothelial cell response to fluid shear stress
2005 StandoutNature
Heparin-Protein Interactions
2002 Standout
Modulation of Integrin Activation by an Entropic Spring in the β-Knee
2010 StandoutNobel
Cutaneous Wound Healing
1999 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularization
1996
Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA
2005 StandoutNobel
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
1993 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 Standout
Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3
1996
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Inhibition of αvβ3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases
2003
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma
2011
Cancer Metastasis: Building a Framework
2006 Standout
The αvintegrin antagonists as novel anticancer agents: an update
2002
Intact Vitronectin Induces Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinases-2 Expression and Enhanced Cellular Invasion by Melanoma Cells
1998
Adhesion molecules in cancer: the role of integrins
1993
Angiogenesis in cancer and other diseases
2000 StandoutNature
The Hallmarks of Cancer
2000 Standout
Integrins and cancer
1996
Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling
2000 StandoutNobel
Angiogenesis in health and disease
2003 Standout
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
1994 Standout
Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All αv Integrins
1998
The von Hippel-Lindau Tumor Suppressor Protein Is Required for Proper Assembly of an Extracellular Fibronectin Matrix
1998 StandoutNobel
Platelet Activation and Atherothrombosis
2007 Standout
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Glioblastoma‐derived tumorospheres identify a population of tumor stem‐like cells with angiogenic potential and enhanced multidrug resistance phenotype
2006
Alginate: Properties and biomedical applications
2011 Standout
The αvβ3 integrin “vitronectin receptor”
1997
The microenvironment of the tumour–host interface
2001 StandoutNature
A polymeric form of fibronectin has antimetastatic effects against multiple tumor types
1996
Clinical Applications of Research on Angiogenesis
1995 Standout
Malignant Gliomas in Adults
2008 Standout
β3-integrin–deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
1999
Cell Migration: A Physically Integrated Molecular Process
1996 Standout
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Sickle-cell disease
2010 Standout
Involvement of the [uPAR:uPA:PAI-1:LRP] Complex in Human Myogenic Cell Motility
2000
Neuroblastoma
2007 Standout
Molecular Role(s) for Integrins in Human Melanoma Invasion
1999
The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development
1999
Mechanisms of angiogenesis and arteriogenesis
2000 Standout
Points of control in inflammation
2002 StandoutNature
Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis.
1996
64Cu-Labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity
2009
Mechanisms and Consequences of Affinity Modulation of Integrin αVβ3 Detected with a Novel Patch-engineered Monovalent Ligand
1999
Azobenzene photoswitches for biomolecules
2011 Standout
Role of integrins in cell invasion and migration
2002
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Matrix Metalloproteinases
1999 Standout
Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes
1998 Standout
Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen.
1994
Cell Migration: Integrating Signals from Front to Back
2003 StandoutScience
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Integrating with integrins.
1994
Identification of the urokinase receptor as an adhesion receptor for vitronectin.
1994
Radiolabeled Multimeric Cyclic RGD Peptides as Integrin αvβ3Targeted Radiotracers for Tumor Imaging
2006
Increased Severity of Local and Systemic Anaphylactic Reactions in Gp49b1-Deficient Mice
2001
The alpha v beta 6 integrin promotes proliferation of colon carcinoma cells through a unique region of the beta 6 cytoplasmic domain.
1994
Monoclonal antibodies to αVβ3 (7E3 and LM609) inhibit sickle red blood cell–endothelium interactions induced by platelet-activating factor
2000
Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic Strategy
1995
Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate
1996
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Integrins and Signal Transduction Pathways: the Road Taken
1995 StandoutScience
Wound Healing--Aiming for Perfect Skin Regeneration
1997 StandoutScience
Integrin Signaling
1999 StandoutScience
Function and Regulation of the β3 Integrins in Hemostasis and Vascular Biology
1995
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
pVHL 19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation
1998 StandoutNobel
The synergistic activity of αvβ3 integrin and pdgf receptor increases cell migration
1998
Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
1997 StandoutScience
Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3.
1996
Imaging Tri-Fusion Multimodality Reporter Gene Expression in Living Subjects
2004 StandoutNobel
pVHL Modification by NEDD8 Is Required for Fibronectin Matrix Assembly and Suppression of Tumor Development
2004 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Integrin activation controls metastasis in human breast cancer
2001
Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide.
2000
Improving Tumor Uptake and Pharmacokinetics of 64Cu-Labeled Cyclic RGD Peptide Dimers with Gly3 and PEG4 Linkers
2009
Requirement of Vascular Integrin α v β 3 for Angiogenesis
1994 StandoutScience
The Molecular Biology of Axon Guidance
1996 StandoutScience
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Geometric Control of Cell Life and Death
1997 StandoutScience
Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography.
2001
Integrin αvβ3‐targeted therapy for Kaposi's sarcoma with an in vitro‐evolved antibody
2002
Works of B. Felding-Habermann being referenced
Role of V Integrins and Vitronectin in Human Melanoma Cell Growth
1992
Involvement of integrin alpha V gene expression in human melanoma tumorigenicity.
1992
Vitronectin and its receptors
1993
Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
1997